News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
111,426 Results
Type
Article (6589)
Company Profile (29)
Press Release (104808)
Section
Business (28678)
Career Advice (166)
Deals (4537)
Drug Delivery (14)
Drug Development (13971)
Employer Resources (8)
FDA (3545)
Job Trends (2560)
News (50794)
Policy (3899)
Tag
2024 BioCapital Digital (1)
2024 BioForest Digital (3)
2024 BioMidwest Digital (2)
2024 Biotech Bay Standard (3)
2024 Biotech Beach Digital (2)
2024 Biotech Beach Standard (3)
2024 Genetown Standard (3)
2024 Lone Star Bio Digital (1)
2025 Lone Star Bio Digital (1)
Academia (702)
Accelerated approval (1)
Adcomms (2)
Allergies (10)
Alliances (9788)
ALS (6)
Alzheimer's disease (218)
Antibody-drug conjugate (ADC) (30)
Approvals (3550)
Artificial intelligence (66)
Autoimmune disease (5)
Automation (9)
Bankruptcy (26)
Best Places to Work (2387)
BIOSECURE Act (1)
Biosimilars (15)
Biotechnology (22)
Bladder cancer (19)
Brain cancer (10)
Breast cancer (64)
Cancer (472)
Cardiovascular disease (37)
Career advice (146)
Career pathing (4)
CAR-T (16)
Cell therapy (85)
Cervical cancer (6)
Clinical research (10929)
Collaboration (205)
Compensation (20)
Complete response letters (1)
COVID-19 (309)
CRISPR (11)
C-suite (29)
Cystic fibrosis (16)
Data (431)
Depression (6)
Diabetes (29)
Diagnostics (1544)
Digital health (5)
Diversity, equity & inclusion (3)
Drug discovery (23)
Drug pricing (9)
Drug shortages (2)
Duchenne muscular dystrophy (38)
Earnings (9420)
Editorial (5)
Employer resources (8)
Events (13986)
Executive appointments (101)
FDA (3819)
Featured Employer (9)
Frontotemporal dementia (1)
Funding (132)
Gene editing (27)
Generative AI (1)
Gene therapy (81)
GLP-1 (112)
Government (467)
Guidances (12)
Healthcare (3609)
Huntington's disease (2)
Immunology and inflammation (18)
Indications (6)
Infectious disease (323)
Inflammatory bowel disease (47)
Inflation Reduction Act (1)
Influenza (4)
Intellectual property (12)
Interviews (26)
IPO (1828)
IRA (4)
Job creations (259)
Job search strategy (126)
Labor market (2)
Layoffs (34)
Leadership (2)
Legal (451)
Liver cancer (27)
Lung cancer (61)
Lymphoma (12)
Management (4)
Manufacturing (79)
MASH (10)
Medical device (2695)
Medtech (2695)
Mergers & acquisitions (2808)
Metabolic disorders (93)
Multiple sclerosis (6)
NASH (2)
Neurodegenerative disease (9)
Neuropsychiatric disorders (1)
Neuroscience (263)
NextGen: Class of 2025 (1236)
Non-profit (525)
Northern California (361)
Now hiring (9)
Obesity (51)
Opinion (20)
Ovarian cancer (6)
Pain (20)
Pancreatic cancer (12)
Parkinson's disease (7)
Partnered (4)
Patents (32)
Patient recruitment (19)
Peanut (3)
People (7611)
Pharmaceutical (6)
Phase I (3771)
Phase II (5142)
Phase III (3303)
Pipeline (217)
Podcasts (1)
Policy (7)
Postmarket research (239)
Preclinical (2008)
Press Release (6)
Prostate cancer (17)
Psychedelics (3)
Radiopharmaceuticals (80)
Rare diseases (68)
Real estate (913)
Recruiting (2)
Regulatory (3315)
Reports (13)
Research institute (565)
Resumes & cover letters (16)
Rett syndrome (3)
RNA editing (2)
RSV (5)
Schizophrenia (6)
Series A (32)
Series B (19)
Service/supplier (3)
Sickle cell disease (17)
Southern California (339)
Special edition (1)
Spinal muscular atrophy (38)
Sponsored (7)
Startups (557)
Stomach cancer (1)
Supply chain (7)
The Weekly (1)
United States (3912)
Vaccines (56)
Venture capitalists (3)
Webinars (2)
Weight loss (25)
Women's health (8)
Worklife (1)
Date
Today (7)
Last 7 days (109)
Last 30 days (493)
Last 365 days (6468)
2025 (1574)
2024 (6767)
2023 (7611)
2022 (10564)
2021 (10745)
2020 (9747)
2019 (8203)
2018 (6306)
2017 (6201)
2016 (5722)
2015 (6267)
2014 (4228)
2013 (3581)
2012 (3832)
2011 (3867)
2010 (3191)
Location
Africa (91)
Alabama (7)
Arizona (38)
Arkansas (1)
Asia (6044)
Australia (1071)
California (866)
Canada (320)
China (66)
Colorado (87)
Connecticut (29)
Delaware (18)
Europe (14580)
Florida (182)
Georgia (56)
Idaho (18)
Illinois (82)
India (5)
Indiana (90)
Iowa (1)
Japan (23)
Kansas (14)
Kentucky (3)
Louisiana (2)
Maine (2)
Maryland (125)
Massachusetts (803)
Michigan (46)
Minnesota (86)
Mississippi (1)
Missouri (16)
Montana (3)
Nebraska (4)
Nevada (4)
New Hampshire (7)
New Jersey (276)
New Mexico (8)
New York (268)
North Carolina (224)
North Dakota (1)
Northern California (361)
Ohio (60)
Oklahoma (4)
Oregon (18)
Pennsylvania (207)
Puerto Rico (1)
Rhode Island (3)
South America (132)
South Carolina (2)
Southern California (339)
Tennessee (13)
Texas (191)
Utah (24)
Virginia (26)
Washington D.C. (3)
Washington State (78)
Wisconsin (9)
111,426 Results for "tissue analytics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
MultiOmic Health and Alloy Therapeutics Collaborate to Discover and Develop Renal Tissue-Targeting Drugs
April 2, 2025
·
4 min read
Press Releases
Repligen Purchases Bioprocessing Analytics Portfolio from 908 Devices
March 4, 2025
·
8 min read
Press Releases
Ibex Medical Analytics Receives First FDA 510(k) Clearance
February 10, 2025
·
4 min read
Press Releases
Caris Life Sciences Publishes Study Featuring the Largest Real-World Cohort of Tissue-Agnostic Indications Revealing Over 20 Percent of Patients Are Eligible for “Pan-Cancer” Therapies
March 20, 2025
·
5 min read
Press Releases
FibroBiologics Announces Scientific Advancement in Confirmation Results of Brain Tissue Repair
April 3, 2025
·
4 min read
Press Releases
Abacus Analytics Receives HFMA Peer Review Designation
January 17, 2025
·
2 min read
Press Releases
Springbok Analytics Announces $5M Series A to Advance Its Leadership in Muscle Health Analysis
January 24, 2025
·
4 min read
Press Releases
Bioanalytical CRO, Veloxity Labs, Partners with Aplos Analytics to Transform Pharmacokinetic and Toxicokinetic Analysis
February 12, 2025
·
1 min read
Press Releases
Quanterix to Acquire Akoya Biosciences, Creating the First Integrated Solution for Ultra-Sensitive Detection of Blood- and Tissue-Based Protein Biomarkers
January 10, 2025
·
15 min read
Drug Development
Springbok Analytics Announces Phase 1 Clinical Trial Evaluating Clenbuterol as FSHD Treatment
Springbok Analytics (www.springbokanalytics.com), a life sciences muscle analytics company, announced today its participation in a Phase 1 Clinical Trial to evaluate safe dosage for clenbuterol as a treatment for Facioscapulohumeral muscular dystrophy (FSHD).
June 12, 2024
·
4 min read
1 of 11,143
Next
